Strepsils Flavour Variant Efficacy Study

• Research type

  Research Study

• Full title

  A multi centre, randomised, double blind, placebo-controlled, parallel group, single dose study of the efficacy of two flavour variants of Strepsils throat lozenges in the relief of sore throat due to upper respiratory tract infection.

• IRAS ID

  8455

• Sponsor organisation

  Reckitt Benckiser Healthcare, UK Ltd

• Eudract number

  2008-00-5596-10

• Research summary

  This study will examine the effects of two new flavour variants of Strepsils lozenges versus anon-medicated placebo in subjects with a sore throat over a period of 2 hours. Subjects with a sore throat who are eligible to take part in the study will receive a lozenge in the clinic. Subjects will complete self-assessment forms which consist of throat soreness scores, difficulty in swallowing scales, throat numbness and a sore throat pain relief scale at regular intervals over a period of 2 hours. Additional questions regarding consumer acceptability of the product will also be contained in a consumer questionnaire. Once the 2 hour study assessment period is complete subjects can seek to treat their sore throat as required.

• REC name

  East of Scotland Research Ethics Service REC 2

• REC reference

  08/S0501/91

• Date of REC Opinion

  18 Nov 2008

• REC opinion

  Favourable Opinion